2 Steps
Maximum: 1 CME cr.
Sign in to view your progression
Program overview
Educational goals
Target audience
Credit designation
Disclosures

Course description:
This learning module summarizes the nomenclature, neurophysiology, and principles in the clinical evaluation and management of female orgasmic disorders.

Video segments in the learning module:
- Video 1: Neural aspects of orgasm
- Video 2: Female orgasmic disorder: nomenclature, classification and diagnosis
- Video 3: Psychotherapeutic approaches to treating female orgasmic disorder (FOD)
- Video 4: Case 1 - Lifelong female orgasm disorder
- Video 5: Diagnosis and treatment of organically-based orgasmic disorders
          - Case 2 - Acquired Female Orgasm Disorder
          - Case 3 - Female Orgasm Illness Syndrome

Faculty Information
Irwin Goldstein, MD
Director, San Diego Sexual Medicine
Director, Sexual Medicine, Alvarado Hospital
Clinical Professor of Surgery, University of California at San Diego
San Diego, California

Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine
University Hospitals Case Medical Center
MacDonald Women's Hospital
Professor, Departments of Reproductive Biology and Psychiatry Case Western Reserve
University School of Medicine
Cleveland, Ohio

Barry R. Komisaruk, PhD
Distinguished Professor, Psychology
Adjunct Professor, Radiology
Rutgers University
Newark, New Jersey

Best practice:
Women present with compromised orgasm including frequency, intensity, timing and pleasure symptoms causing bothersome sexual dysfunction. Orgasm may also lead to peripheral and/or central aversive distressing symptoms causing sexual dysfunction. All these forms of female orgasm disorder should be investigated and managed.

Current practice:
If a health care practitioner asks about orgasm, typically it is limited to whether or not a woman can achieve an orgasm.

Resulting gaps:
Patients are rarely treated for orgasm problems because their HCPs do not complete a proper assessment.

Outcome indicated/Improvement in:
Patients have multiple versions of orgasmic dysfunction and each is managed logically and rationally.

Learning objectives:
(1) Differentiate among different types of orgasm disorders.
​(2) Describe various aspects of orgasm compromise.

Medical health care practitioners (MDs, DOs, PAs, NPs, etc.) in any field (Sexual Medicine, Obstetrics & Gynecology, Internal Medicine, Family Medicine, Urology, etc.) who would like to address sexual health in caring for their female patients.

ISSWSH Learner Notification

Module 5: Management of orgasm disorders, from anatomy through diagnosis to treatment
Dr. I. Goldstein, Dr. S. Kingsberg and Dr. B. Komisaruk

January 1, 2019 – January 1, 2021
Online

Acknowledgment of Financial Commercial Support
Valeant Pharmaceuticals North America LLC

Acknowledgment of In-Kind Commercial Support (Only for ACCME, ANCC and ACPE)
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, pass the self-assessment questionnaire with a score of 80% or higher and complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women’s Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this internet activity enduring material for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After attending this program you should be able to:

  1. Understand the broad epidemiology, prevalence, classification systems and models for female sexual disorders in clinical practice
  2. Identify changes in definitions in the transition from DSM IV-TR to DSM 5

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.

First

Last

Commercial Interest

I.

Goldstein

Coloplast:Consultant, AbbVie:Research Grant Site Principal Investigator, AMAG:Speakers Bureau, AMAG:Research Grant Overall Principal Investigator, Duchesnay:Consultant, Strategic Science & Technologies:Consultant

S.

Kingsberg

IVIX:Consultant, Endoceutics:Consultant, AMAG Pharmaceuticals, Inc.:Scientific/Medical Advisory Board Member, Palatin Technologies,
Inc.:Consultant, Pfizer, Lupin, Materna:Consultant, Dare:Research Grant Site Principal Investigator

B.

Komisaruk

Apex Neuro:Consultant

Management of orgasm disorders, from anatomy through diagnosis to treatment
Self-assessment & Certificate

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies